Results 191 to 200 of about 636 (203)

Actualización en la profilaxis a largo plazo en los angioedemas hereditarios con C1 inhibidor disminuido

Actualidad Médica, 2023
exaly  

The Cochrane Library

Cochrane Database of Systematic Reviews, 2020
Daniel Simancas-Racines, Mª José Martínez, Airton T Stein   +2 more
exaly  

Sitagliptin and Angioedema

Annals of Internal Medicine, 2017
Robin, Arcani, Sonia, Martinez, Stéphane, Gayet   +2 more
openaire   +2 more sources

[What are angioedemas and how are they classified?]

Die Dermatologie
Janina Hahn, Andreas Recke
exaly  

The Cochrane Library

Cochrane Database of Systematic Reviews
Michael Frese, Constance H Katelaris, Kerry Mills   +2 more
exaly   +2 more sources

[Hereditary angioedema].

Ugeskrift for laeger, 2004
Bygum, Anette, Zachariae, H., Dyerberg, J., Kragballe, Knud   +3 more
openaire   +2 more sources

Urticaria-angioedema and nonurticarial angioedema

Current Opinion in Otolaryngology & Head and Neck Surgery, 2000
openaire   +1 more source

Therapeutic Potential of C1-Inhibitor in Vascular Diseases and Beyond

Arteriosclerosis, Thrombosis, and Vascular Biology
Steven P Grover, Linda Sundler Björkman, Harish Eswaran   +2 more
exaly  

[Clinical aspects and diagnostics of mast cell-mediated angioedemas].

Die Dermatologie
exaly  

Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Angioedemas, Hereditary, Date of authorisation: 22/11/2018, Status: Authorised

Case Medical Research
exaly